Aerie Pharmaceuticals Inc logo

Aerie Pharmaceuticals Inc Share Price (NASDAQ: AERI)

▲

-15.25

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 18 Nov 2022

Check the interactive Aerie Pharmaceuticals Inc Stock chart to analyse performance

Aerie Pharmaceuticals Inc Key Stats

Check Aerie Pharmaceuticals Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$15.25
Open
$15.24
Market Capitalization
$753.6M
Today's Volume
$1.2M
Revenue TTM
$213.9M
EBITDA
$-6.5M
Earnings Per Share (EPS)
$-1.47
Dividend Yield
0.0%
Profit Margin
-17.09%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2255.01%

Global Institutional Holdings in Aerie Pharmaceuticals Inc

  • Name

    Holdings %

  • Deerfield Management Co

    9.82%

  • Vanguard Group Inc

    5.50%

  • Bank of America Corp

    5.26%

  • Jefferies Group Inc

    4.78%

  • Schroder Investment Management Group

    4.24%

  • UBS Group AG

    3.46%

Analyst Recommendation on Aerie Pharmaceuticals Inc Stock

Rating
Trend

Buy

    77%Buy

    11%Hold

    11%Sell

Based on 9 Wall street analysts offering stock ratings for Aerie Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

About Aerie Pharmaceuticals Inc

Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma or ocular hypertension. The company also develops AR-15512 to treat signs and symptoms of dry eye; and AR-1105 and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM Biomedical. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina.
Organization
Aerie Pharmaceuticals Inc
Employees
376
CEO
Mr. Raj Kannan
Industry
Health Technology

Important FAQs about investing in AERI Stock from India :

What is Aerie Pharmaceuticals Inc share price today?

Aerie Pharmaceuticals Inc share price today is as on at the close of the market. Aerie Pharmaceuticals Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Aerie Pharmaceuticals Inc share?

Aerie Pharmaceuticals Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Aerie Pharmaceuticals Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Aerie Pharmaceuticals Inc Stock (AERI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aerie Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aerie Pharmaceuticals Inc Shares .

What is the minimum amount required to buy Aerie Pharmaceuticals Inc Stock (AERI) from India?

Indian investors can start investing in Aerie Pharmaceuticals Inc (AERI) shares with as little as ₹88.2687 or $1 (as of September 15, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.69 in Aerie Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025). Learn more about fractional shares .

What are the returns that Aerie Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Aerie Pharmaceuticals Inc stock has given 0.0% share price returns and 20.27% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?